Ms Yvette D Schwenk, MS, LPE-I in Beebe, AR - Psychologist

Ms Yvette D Schwenk, MS, LPE-I is a Psychologist based in Beebe, Arkansas. Ms Yvette D Schwenk is licensed to practice in Arkansas (license number 93-14EI) and her current practice location is 149 Cane Creek Rd, Beebe, Arkansas. She can be reached at her office (for appointments etc.) via phone at (501) 831-5180.

NPI number for Ms Yvette D Schwenk is 1609298488 and her current mailing address is 149 Cane Creek Rd, Beebe, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1609298488.

Contact Information

	Ms Yvette D Schwenk, MS, LPE-I
	149 Cane Creek Rd, Beebe, AR 72012-9764
	(501) 831-5180
	Not Available

Healthcare Provider's Profile

Full Name	Ms Yvette D Schwenk
Gender	Female
Speciality	Psychologist
Location	149 Cane Creek Rd, Beebe, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1609298488
Provider Enumeration Date: 01/13/2014
Last Update Date: 01/13/2014

Medical Identifiers

Medical identifiers for Ms Yvette D Schwenk such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609298488	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	93-14EI (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Yvette D Schwenk is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Yvette D Schwenk, MS, LPE-I 149 Cane Creek Rd, Beebe, AR 72012-9764 Ph: (501) 831-5180	Ms Yvette D Schwenk, MS, LPE-I 149 Cane Creek Rd, Beebe, AR 72012-9764 Ph: (501) 831-5180

News Archive

North American legal injection drug site helps decrease overdose deaths, study shows

North America's only authorized facility for injecting illegal drugs has helped cut drug overdose deaths significantly in the Vancouver community where it is located and "should be used as a model in other cities," according to a study published on Monday in the Lancet, Reuters reports (Dowd, 4/18).

Nanobody works against all SARS-CoV-2 variants of concern in animal model

Researchers based in Belgium have developed a new antibody drug that is highly successful at neutralizing coronavirus disease 2019 (COVID-19) in Syrian hamsters. The new biologic was administered to the rodents and was found to be equally successful at neutralizing the original severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain, and also the new mutant variants, such as the South African and UK strains.

Researchers develop promising reconstruction method based on 3D-printed esophageal grafts

The loss of complete segments of the esophagus often results from treatments for esophageal cancer or congenital abnormalities, and current methods to re-establish continuity are inadequate.

GAO: Smooth and timely launch of health exchanges unsure

The report by the Government Accountability Office noted that the federal government has missed several deadlines, and there is a risk it won't be ready to open the online marketplaces Oct. 1. But the report also noted some positive signs.

Ms Yvette D Schwenk, MS, LPE-I - Psychologist in Beebe, AR